Breast Cancer

IF 7.8 2区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

Cold Spring Harbor perspectives in medicine Pub Date : 2024-05-01 DOI:10.1101/cshperspect.a041729

Jane E. Visvader, Jeffrey M. Rosen, Samuel Aparicio

引用次数: 0

Abstract

Breast cancer kills hundreds of thousands of people every year. Rapid progress over the past two decades has increased our understanding of the genetic and environmental risk factors for disease. It has also shed light on drivers of tumor progression and the molecular landscape underpinning tumor heterogeneity, as well as the role of the microenvironment and the immune system. These strides forward should lead to more effective and tailored therapies for early- and late-stage patients.

查看原文本刊更多论文

乳腺癌

每年有数十万人死于乳腺癌。过去二十年来，研究取得了突飞猛进的进展，使我们对疾病的遗传和环境风险因素有了更深入的了解。它还揭示了肿瘤进展的驱动因素、肿瘤异质性的分子结构以及微环境和免疫系统的作用。这些进步应能为早期和晚期患者带来更有效、更有针对性的疗法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cold Spring Harbor perspectives in medicine MEDICINE, RESEARCH & EXPERIMENTAL-

CiteScore

14.30

自引率

1.90%

发文量

审稿时长

4-8 weeks

期刊介绍： Cold Spring Harbor Perspectives in Medicine is a monthly online publication comprising reviews on different aspects of a variety of diseases, covering everything from the molecular and cellular bases of disease to translational medicine and new therapeutic strategies. Cold Spring Harbor Perspectives in Medicine is thus unmatched in its depth of coverage and represents an essential source where readers can find informed surveys and critical discussion of advances in molecular medicine.